Desmopressin vs Vasopressin

Desmopressin is a modified vasopressin that acts mainly on kidney V2 receptors and lasts longer, with little blood-pressure effect. Native vasopressin acts on both V1 (vascular) and V2 (renal) receptors.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

Desmopressin

A synthetic vasopressin analogue selective for the V2 receptor — strongly antidiuretic, with little effect on blood pressure.

BEST STUDIED FOR

Nootropic & neuro

Read the cited profile →

🧪

Vasopressin

The posterior-pituitary nonapeptide that controls water balance and blood pressure, and a central regulator of social and anxiety-related behaviour.

BEST STUDIED FOR

Nootropic & neuro

Read the cited profile →

SIDE BY SIDE

	Desmopressin	Vasopressin
The key difference	Selective V2 agonist, long-acting	Native V1/V2 agonist
Class	Nootropic & neuro	Nootropic & neuro
Mechanism	Two modifications (deamination at position 1, D-arginine at 8) make desmopressin longer-acting and V2-selective.	Peripherally, AVP acts at V2 (kidney) and V1a (vascular) receptors.
Status	Registered medicine for central diabetes insipidus, nocturnal enuresis and mild bleeding disorders; also used as a diagnostic test in Cushing’s syndrome.	Registered medicine (vasodilatory shock, diabetes insipidus); intranasal research in human social behaviour.
Reported safety signals	Hyponatraemia (water intoxication) is the key documented risk.	Clinical use carries vasoconstriction and fluid-balance risks; research doses in behavioural studies are small.
A key study	Describes desmopressin’s enhanced antidiuretic potency, reduced pressor activity and longer action than vasopressin. (Ann Intern Med 1985, PMID 3893256)	Reviews vasopressin’s systemic antidiuretic and cardiovascular roles across species. (Biomedicines 2021, PMID 33477721)

WHEN TO RESEARCH WHICH

Desmopressin for antidiuretic research; vasopressin for vascular and broader receptor physiology. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[Desmopressin] Desmopressin — Ann Intern Med 1985. PMID 3893256
[Desmopressin] Intranasal desmopressin-induced hyponatremia — Pharmacotherapy 1996. PMID 8700794
[Desmopressin] A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero? — Biomolecules 2025. PMID 40723839
[Vasopressin] The Biology of Vasopressin — Biomedicines 2021. PMID 33477721
[Vasopressin] Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities — Endocrinology 2022. PMID 35863332
[Vasopressin] Oxytocin, vasopressin, and human social behavior — Front Neuroendocrinol 2009. PMID 19505497

FREQUENTLY ASKED

What is the difference between Desmopressin and Vasopressin?

What is the regulatory status of Desmopressin and Vasopressin?

Desmopressin: Registered medicine for central diabetes insipidus, nocturnal enuresis and mild bleeding disorders; also used as a diagnostic test in Cushing’s syndrome. Vasopressin: Registered medicine (vasodilatory shock, diabetes insipidus); intranasal research in human social behaviour.

What safety signals have been reported?

Desmopressin: Hyponatraemia (water intoxication) is the key documented risk. Vasopressin: Clinical use carries vasoconstriction and fluid-balance risks; research doses in behavioural studies are small.

Which studies is this comparison based on?

For Desmopressin: “Desmopressin” (PMID 3893256); “Intranasal desmopressin-induced hyponatremia” (PMID 8700794); “A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?” (PMID 40723839). For Vasopressin: “The Biology of Vasopressin” (PMID 33477721); “Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities” (PMID 35863332); “Oxytocin, vasopressin, and human social behavior” (PMID 19505497).